|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| IBC's Formulation Strategies for Biopharmaceuticals | ||||||||||||||||
| May 21, 2003 | ||||||||||||||||
|
IBC Life Sciences, Wyndham Philadelphia Hotel, Philadelphia, PA September 22-24, 2003 Attend IBC’s Formulation Strategies for Biopharmaceuticals conference to obtain the solutions to your most pressing problems in developing formulations for protein & peptide therapeutics. Specifically, you will learn from leaders in industry and academia with new reports on protein stability, therapeutic specific formulations, practical issues involving analytical methods and process scale-up, as well as the potential for using protein engineering to improve stability profiles. Plus, for the first time, the Formulations meeting will be co-located with IBC’s Protein & Peptide Drug Delivery – expanding your networking opportunities and giving you the opportunity to attends sessions for this conference when you register for Formulations. |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Invited Speakers: | Keynote Presentations: John Carpenter, Ph.D., Co-Director, Center for Pharmaceutical Biotechnology, University of Colorado Steven J. Shire, Ph.D., Senior Scientist/Group Leader, Pharmaceutical R&D, Genentech, Inc. |
|||||||||||||||
| Deadline for Abstracts: | -` | |||||||||||||||
| Registration: | Phone (508) 616-5550 x1004 Fax (508) 616-5522+ Email reg@ibcusa.com Online www.LifeSciencesInfo.com/formulations | |||||||||||||||
| E-mail: | reg@ibcusa.com | |||||||||||||||
| Posted by: | James G. Prudhomme | |||||||||||||||
| Host: | host-65-124-112-226.ibcusa.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||